ArticleJournal of health economics and outcomes research2022

Chronic Myeloid Leukemia: Part II-Cost of Care Among Patients in Advanced Phases or Later Lines of Therapy in Chronic Phase in the United States from a Commercial Perspective.

Ehab L Atallah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.